Summary : TECHNOLOGY TRANSFER FOR CEPHALOSPORIN-C (INTERMEDIATE) & 7-AMINOCEPHALOSPORANIC ACID (7-ACA) BULK DRUG PROJECT CAPACITY/ANNUM:1000 METRIC TONNE/ANNUM

Organization Name : KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LIMITED BENGALURU

Organization Details:
Organization Name: KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LIMITED BENGALURU
Country: India
Address: KAPL HOUSE
Contact Person: gmplant@kaplindia.com, 7acaproject@kaplindia.com
Notice Details:
Notice Type: Tender Notice
Bidding Type: International Competitive Bidding
Notice No: KAPL-HO/SR/1412
Description: The Organization envisages to establish a Bulk Drug Manufacturing Plant for the intermediate 7-ACA (7 Amino Cephalosporanic Acid) and invites Tender for “Technology Transfer for CEPHALOSPORIN-C & 7-AMINOCEPHALOSPORANIC ACID” (7-ACA) Bulk Drug Project at Ujjain (M.P.), India.

Any firm who is interested in participating in the tender for the “Technology Transfer for CEPHALOSPORIN-C & 7-AMINOCEPHALOSPORANIC ACID” (7-ACA) Bulk Drug Project at Ujjain (M.P.), India. as mentioned above for 7-ACA Project at Ujjain, Madhya Pradesh, India may submit their Bids in Two separate Sealed Envelopes subscribing as 1. “Interest-Free EMD and Technical Offer for “Technology Transfer for CEPHALOSPORIN-C & 7-AMINOCEPHALOSPORANIC ACID” (7-ACA) Bulk Drug Project at Ujjain (M.P.), India. & 2. “Financial Offer for “Technology Transfer for CEPHALOSPORIN-C & 7-AMINOCEPHALOSPORANIC ACID” (7-ACA) Bulk Drug Project at Ujjain (M.P.), India.

The Tender responses must be submitted in Two sealed envelopes as mentioned above to the “HOD Purchase Department”, Karnataka Antibiotics and Pharmaceuticals Ltd., No14, 2nd Main, 2nd Phase, Peenya Industrial Area, Bengaluru – 560 058, India. Phone: 080-28394669 on or before Last Date mentioned in each Tender Schedule.
Deadline: 24 Aug 2023
Updates:
Soft Copy: Document (1.2MB)

About Authority: Karnataka Antibiotics & Pharmaceuticals Limited (KAPL), a Government of India Enterprise under the Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals. The company was incorporated in 1981 on the Hathi Committee's recommendations to supply life-saving drugs to the general public at an affordable price. The plant started its commercial production in 1984. The company is PIC/S GMP Certified, ISO 9001:2015; ISO 14001:2015; ISO 45001:2018 & WHO-GMP accredited. The Existing factories are located in Bengaluru & Dharwad, India. The upcoming factory is at Ujjain, India.